HeartWare International, Inc.
(NASDAQ : HTWR)

( )
HTWR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -1.12%104.760.8%$723.21m
TMOThermo Fisher Scientific, Inc. 1.13%430.261.0%$636.99m
MDTMedtronic Plc -0.41%104.370.6%$521.13m
ISRGIntuitive Surgical, Inc. 3.75%666.022.4%$486.52m
DHRDanaher Corp. 0.70%207.240.7%$422.51m
QDELQuidel Corp. -0.51%198.987.7%$409.86m
INOInovio Pharmaceuticals, Inc. -4.01%16.985.9%$409.21m
BDXBecton, Dickinson & Co. -2.01%223.851.0%$404.08m
DXCMDexCom, Inc. 1.64%398.137.9%$314.29m
BSXBoston Scientific Corp. 0.16%38.611.0%$283.50m
SYKStryker Corp. 0.29%203.501.3%$277.86m
VARVarian Medical Systems, Inc. -0.16%172.479.1%$260.86m
BAXBaxter International, Inc. -1.53%79.021.8%$242.10m
ALGNAlign Technology, Inc. 0.08%322.576.4%$231.75m
EWEdwards Lifesciences Corp. -3.38%78.700.4%$218.35m

Company Profile

HeartWare International, Inc. develops and manufactures small implantable heart pumps or ventricular assist devices for the treatment of advanced heart failure. The company offers HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. It is also developing the Miniaturized Ventricular Assist Device, a miniaturized device intended for chronic heart failure patients. HeartWare International, Inc. sells and markets its products through clinical studies in the United States, as well as directly to cardiac centers and hospitals internationally. The company is headquartered in Framingham, Massachusetts.